BNP Paribas Financial Markets’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.2M | Buy |
1,905,472
+764,366
| +67% | +$12.1M | 0.01% | 1262 |
|
|
2025
Q4 | $20.8M | Buy |
1,141,106
+1,091,241
| +2,188% | +$18.4M | 0.01% | 1153 |
|
|
2025
Q3 | $731K | Buy |
49,865
+18,564
| +59% | +$318K | ﹤0.01% | 3349 |
|
|
2025
Q2 | $570K | Sell |
31,301
-57,509
| -65% | -$1.17M | ﹤0.01% | 3248 |
|
|
2025
Q1 | $1.76M | Buy |
88,810
+12,038
| +16% | +$208K | ﹤0.01% | 2434 |
|
|
2024
Q4 | $1.32M | Sell |
76,772
-674,016
| -90% | -$12.7M | ﹤0.01% | 2643 |
|
|
2024
Q3 | $15M | Buy |
750,788
+85,250
| +13% | +$1.33M | 0.01% | 991 |
|
|
2024
Q2 | $7.44M | Sell |
665,538
-67,382
| -9% | -$565K | 0.01% | 1227 |
|
|
2024
Q1 | $4.84M | Buy |
732,920
+442,315
| +152% | +$2.42M | 0.01% | 1477 |
|
|
2023
Q4 | $1.31M | Buy |
290,605
+96,653
| +50% | +$358K | ﹤0.01% | 2223 |
|
|
2023
Q3 | $694K | Buy |
193,952
+27,995
| +17% | +$108K | ﹤0.01% | 2540 |
|
|
2023
Q2 | $612K | Sell |
165,957
-255,759
| -61% | -$948K | ﹤0.01% | 2481 |
|
|
2023
Q1 | $1.4M | Buy |
421,716
+235,185
| +126% | +$813K | ﹤0.01% | 2091 |
|
|
2022
Q4 | $724K | Sell |
186,531
-53,122
| -22% | -$164K | ﹤0.01% | 2360 |
|
|
2022
Q3 | $582K | Buy |
239,653
+197,752
| +472% | +$474K | ﹤0.01% | 2880 |
|
|
2022
Q2 | $83K | Buy |
41,901
+40,717
| +3,439% | +$80.1K | ﹤0.01% | 3413 |
|
|
2022
Q1 | $2.17K | Hold |
1,184
| – | – | ﹤0.01% | 3900 |
|
|
2021
Q4 | $1.67K | Sell |
1,184
-204
| -15% | -$268 | ﹤0.01% | 4013 |
|
|
2021
Q3 | $1.57K | Sell |
1,388
-185
| -12% | -$259 | ﹤0.01% | 3831 |
|
|
2021
Q2 | $2.52K | Sell |
1,573
-8,214
| -84% | -$14.5K | ﹤0.01% | 3857 |
|
|
2021
Q1 | $17.2K | Sell |
9,787
-3,163
| -24% | -$7.24K | ﹤0.01% | 3782 |
|
|
2020
Q4 | $25.3K | Sell |
12,950
-1,478
| -10% | -$3.11K | ﹤0.01% | 3798 |
|
|
2020
Q3 | $34.5K | Buy |
14,428
+11,482
| +390% | +$31.5K | ﹤0.01% | 3632 |
|
|
2020
Q2 | $8.63K | Sell |
2,946
-18,122
| -86% | -$52.1K | ﹤0.01% | 3765 |
|
|
2020
Q1 | $60.7K | Buy |
21,068
+15,219
| +260% | +$52.6K | ﹤0.01% | 3450 |
|
|
2019
Q4 | $23.4K | Sell |
5,849
-521
| -8% | -$2.27K | ﹤0.01% | 3953 |
|
|
2019
Q3 | $28.3K | Buy |
6,370
+3,981
| +167% | +$16.6K | ﹤0.01% | 3788 |
|
|
2019
Q2 | $9.24K | Sell |
2,389
-1,726
| -42% | -$7.62K | ﹤0.01% | 4115 |
|
|
2019
Q1 | $15.6K | Buy |
+4,115
| New | +$14.5K | ﹤0.01% | 3956 |
|
Other funds holding ADMA
VCM
VPM
N
